AgingResearch.NewsJoin free

Dermatomyositis

There are 6 papers on dermatomyositis in aging research: 3 observational studies in people, 2 reviews. The newest story, Nov 4, 2026: “Rare autoimmune rheumatic diseases linked to higher death rates”.

Disease

6 papers study it3 more mention it5 findings

MeSH

1 new paper in 30 daysSee all 9 papers on dermatomyositis

“higher risk of dermatomyositis (HR 2.18, 95% CI 1.24-3.53)”
Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With DiabetesACR open rheumatology2026doi:10.1002/acr2.90046
  • Humans3

Interventions

2

Mycophenolate mofetil

downin humans1

1 study

  1. Mycophenolate mofetil decreases dermatomyositis in humans (statin-induced dermatomyositis).

    “Treatment with systemic corticosteroids and mycophenolate mofetil resulted in gradual improvement.”

    Human trialstatin-induced dermatomyositisfemales

    Dermatomyositis Mimicking Statin-Induced Myopathy in A 62-Year-Old Woman

    European journal of case reports in internal medicine

More on Mycophenolate mofetil

Atorvastatin

upin humans1

1 study

  1. Atorvastatin induces dermatomyositis in humans (statin-induced dermatomyositis).

    “who developed progressive proximal muscle weakness, myalgias, and joint discomfort shortly after initiating atorvastatin therapy”

    Human trialstatin-induced dermatomyositisfemales

    Dermatomyositis Mimicking Statin-Induced Myopathy in A 62-Year-Old Woman

    European journal of case reports in internal medicine

More on Atorvastatin

Associations

3

DPP-4 inhibitors

upin humans1HR 2.18

1 study

  1. DPP-4 inhibitors are linked with a higher risk of dermatomyositis in humans (compared with GLP-1RA in patients with type 2 diabetes) (HR 2.18, 95% CI 1.24-3.53).

    “higher risk of dermatomyositis (HR 2.18, 95% CI 1.24-3.53)”

    Humanscompared with GLP-1RA in patients with type 2 diabetes3 yearsn = 118,419

    Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes

    ACR open rheumatology

More on DPP-4 inhibitors

Cancer

upin humans1

1 study

  1. Dermatomyositis is associated with cancer in dermatomyositis.

    “Dermatomyositis (DM) is a cardinal example of an autoimmune rheumatic disease associated with an increased risk of cancer.”

    Reviewin dermatomyositis

    Autoantibodies as biomarkers of cancer risk in dermatomyositis

    JID innovations : skin science from molecules to population health

More on Cancer

Lung cancer

upin humans1RR 3.18

1 study

  1. Dermatomyositis is linked with a higher risk of lung cancer in humans following DM diagnosis (1.05 vs 0.33; RR 3.18, 95% CI 1.71-5.47).

    “with increased CIR for lung cancer vs controls (1.05 vs 0.33; RR 3.18, 95% CI 1.71-5.47).”

    Humansfollowing DM diagnosis

    Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia

    The Journal of rheumatology

More on Lung cancer

Trial sponsors

Funding

1 grant since 2025

Japan Society for the Promotion of Science¥6.5M

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 15 papers in 12 months
Rheumatology

Rare autoimmune rheumatic diseases linked to higher death rates

Age- and sex-adjusted death rates were 2.6 times the general population’s rate in 2013 and 2.3 times in 2020.Age- and sex-adjusted death rates were 2.6 times the general population’s rate in 2013 and 2.3 times in 2020.

Cohort studyPopulations
Paper

Related